Cargando…

Mucolytic Effectiveness of Tyloxapol in Chronic Obstructive Pulmonary Disease - A Double-Blind, Randomized Controlled Trial

OBJECTIVE: Mucoactive drugs should increase the ability to expectorate sputum and, ideally, have anti-inflammatory properties. The aim of the study was to evaluate the mucolytic activity of Tyloxapol compared to saline (0.9%) in COPD. DESIGN: A randomized, placebo-controlled, double-blinded crossove...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koppitz, Martin, Eschenburg, Charlotte, Salzmann, Emilia, Rosewich, Martin, Schubert, Ralf, Zielen, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911120/ https://www.ncbi.nlm.nih.gov/pubmed/27308826 http://dx.doi.org/10.1371/journal.pone.0156999

Ejemplares similares

Administration of maximum dose of mucolytic solution before upper endoscopy – a double-blind, randomized trial
por: Stepan, Michal, et al.
Publicado: (2023)

Cell distribution and cytokine levels in induced sputum from healthy subjects and patients with asthma after using different nebulizer techniques
por: Koc-Günel, Sinem, et al.
Publicado: (2018)

Induction of Bronchial Tolerance After 1 Cycle of Monophosphoryl-A-Adjuvanted Specific Immunotherapy in Children With Grass Pollen Allergies
por: Rosewich, Martin, et al.
Publicado: (2016)

Mucolytics for acute exacerbations of chronic obstructive pulmonary disease: a meta-analysis
por: Papadopoulou, Efthymia, et al.
Publicado: (2023)

Role of mucolytics in the management of COPD
por: Poole, Phillippa J
Publicado: (2006)

A novel thiol-saccharide mucolytic for the treatment of muco-obstructive lung diseases
por: Addante, Annalisa, et al.
Publicado: (2023)

Tyloxapol inhibits RANKL-stimulated osteoclastogenesis and ovariectomized-induced bone loss by restraining NF-κB and MAPK activation
por: Guo, Wen, et al.
Publicado: (2021)

A conservative treatment for chronic obstructive sialoadenitis by intraductal instillation of mucolytic, steroids and antibiotic solution
por: Lorusso, Francesco, et al.
Publicado: (2021)

Clinical Efficacy of Carbocysteine in COPD: Beyond the Mucolytic Action
por: Pace, Elisabetta, et al.
Publicado: (2022)

Mucolytic Agents and Statins Use is Associated with a Lower Risk of Acute Exacerbations in Patients with Bronchiectasis-Chronic Obstructive Pulmonary Disease Overlap
por: Su, Vincent Yi-Fong, et al.
Publicado: (2018)

Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine
por: Rogliani, Paola, et al.
Publicado: (2019)

Calprotectin as a New Sensitive Marker of Neutrophilic Inflammation in Patients with Bronchiolitis Obliterans
por: Jerkic, S. P., et al.
Publicado: (2020)

Efficacy of mucolytics and steam therapy in the management of sinusitis among Indians
por: S Balakrishnan, Rajalakshmi, et al.
Publicado: (2023)

Multifaceted Beneficial Effects of Erdosteine: More than a Mucolytic Agent
por: Cazzola, Mario, et al.
Publicado: (2020)

Mucolytic and Antioxidant Properties of Carbocysteine as a Strategy in COVID-19 Therapy
por: Bianco, Andrea, et al.
Publicado: (2022)

A Quality Improvement Approach to Influence Value-based Mucolytic Use in the PICU
por: Gillis, Holly Catherine, et al.
Publicado: (2021)

A Role for Mucolytics and Expectorants in Aiding Inhaled Therapies in Asthma? [Response To Letter]
por: Kurukulaaratchy, Ramesh J, et al.
Publicado: (2021)

Repurposing the mucolytic agent ambroxol for treatment of sub-acute and chronic ischaemic stroke
por: Patzwaldt, Kristin, et al.
Publicado: (2023)

Mucolytic treatment of chronic rhinosinusitis in a murine model of primary ciliary dyskinesia
por: Yin, Weining, et al.
Publicado: (2023)

Postinfectious Bronchiolitis Obliterans in Children: Diagnostic Workup and Therapeutic Options: A Workshop Report
por: Jerkic, Silvija-Pera, et al.
Publicado: (2020)

Epigenetic regulation of inflammation by microRNAs in post‐infectious bronchiolitis obliterans
por: Duecker, Ruth P, et al.
Publicado: (2022)

Mucolytics for Intubated Asthmatic Children: A National Survey of United Kingdom Paediatric Intensive Care Consultants
por: Snoek, Aarjan Peter, et al.
Publicado: (2015)

Taste Masked Orally Disintegrating Pellets of Antihistaminic and Mucolytic Drug: Formulation, Characterization, and In Vivo Studies in Human
por: Taj, Yasmeen, et al.
Publicado: (2014)

Ex-vivo mucolytic and anti-inflammatory activity of BromAc in tracheal aspirates from COVID-19
por: Coelho dos Reis, Jordana Grazziela A., et al.
Publicado: (2022)

Tracking of Infused Mesenchymal Stem Cells in Injured Pulmonary Tissue in Atm-Deficient Mice
por: Baer, Patrick C., et al.
Publicado: (2020)

Oxidative stress-driven pulmonary inflammation and fibrosis in a mouse model of human ataxia-telangiectasia
por: Duecker, Ruth, et al.
Publicado: (2017)

Mucolytics as Adjuvant Agent to Improve Helicobacter pylori Eradication Rate: Still Long and Winding Road to Positive Results
por: Yoon, Hyuk, et al.
Publicado: (2015)

Does Premedication with Mucolytic Agents Improve Mucosal Visualization during Oesophagogastroduodenoscopy: A Systematic Review and Meta-Analysis
por: Burke, Eoghan, et al.
Publicado: (2021)

Ghrelin Treatment of Cachectic Patients with Chronic Obstructive Pulmonary Disease: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
por: Miki, Keisuke, et al.
Publicado: (2012)

A Double-Blind, Randomized, Placebo-controlled Trial of Long-Term Doxycycline Therapy on Exacerbation Rate in Patients with Stable Chronic Obstructive Pulmonary Disease
por: Allinson, James P., et al.
Publicado: (2023)

Preventive nebulization of mucolytic agents and bronchodilating drugs in invasively ventilated intensive care unit patients (NEBULAE): study protocol for a randomized controlled trial
por: van der Hoeven, Sophia M., et al.
Publicado: (2015)

Safety, tolerability, and impact on allergic inflammation of autologous E.coli autovaccine in the treatment of house dust mite asthma - a prospective open clinical trial
por: Rose, Markus A, et al.
Publicado: (2011)

Inhibition of inflammatory responses by ambroxol, a mucolytic agent, in a murine model of acute lung injury induced by lipopolysaccharide
por: Su, Xiao, et al.
Publicado: (2004)

Molecular studies of phages-Klebsiella pneumoniae in mucoid environment: innovative use of mucolytic agents prior to the administration of lytic phages
por: Pacios, Olga, et al.
Publicado: (2023)

A randomized, double-blind, placebo-controlled study assessing the safety and tolerability of regadenoson in subjects with asthma or chronic obstructive pulmonary disease
por: Prenner, Bruce M., et al.
Publicado: (2012)

Adjunctive Treatment with Rhodiola Crenulata in Patients with Chronic Obstructive Pulmonary Disease – A Randomized Placebo Controlled Double Blind Clinical Trial
por: Chuang, Ming-Lung, et al.
Publicado: (2015)

Effects of the Chinese herb formula Yufeining on stable chronic obstructive pulmonary disease: A randomized, double-blind, placebo-controlled trial
por: Hong, Minli, et al.
Publicado: (2018)

Survival and Functional Immune Reconstitution After Haploidentical Stem Cell Transplantation in Atm-Deficient Mice
por: Duecker, Ruth Pia, et al.
Publicado: (2021)

Oil supplementation with a special combination of n-3 and n-6 long-chain polyunsaturated fatty acids does not protect for exercise induced asthma: a double-blind placebo-controlled trial
por: Dreßler, M., et al.
Publicado: (2020)

Double-Blind Randomized Trial of Pirfenidone in Chinese Idiopathic Pulmonary Fibrosis Patients
por: Huang, Hui, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_nu3c1nesfprps424kpmh8b106b